Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays

被引:35
作者
Abbanat, Darren [1 ]
Shang, Wenchi [1 ]
Amsler, Karen [1 ]
Santoro, Colleen [1 ]
Baum, Ellen [1 ]
Crespo-Carbone, Steven [1 ]
Lynch, A. Simon [1 ]
机构
[1] Janssen Res & Dev, Raritan, NJ 08869 USA
关键词
Ceftobiprole; Biofilm; Staphylococcus; Antibiotic resistance; METHICILLIN-RESISTANT; VANCOMYCIN; DAPTOMYCIN; PHARMACOKINETICS; ENDOCARDITIS; EPIDERMIDIS; MODEL; SULFAMETHOXAZOLE; ANTIBIOTICS; COMBINATION;
D O I
10.1016/j.ijantimicag.2013.09.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to evaluate the in vitro efficacy of ceftobiprole and comparator antibiotics, either alone or in combination, in staphylococcal MBECTM (minimum biofilm eradication concentration) and colony biofilm assays at dilutions of the maximum free-drug plasma concentration attained during clinical use (fC(max)). Staphylococci tested included meticillin-susceptible and meticillin-resistant Staphylococcus aureus (n = 6) and Staphylococcus epidermidis (n = 2). Relative to no-drug controls, after 7 days of exposure ceftobiprole concentrations from 1/4 fC(max) to fC(max) generally decreased CFUs in MBEC or colony biofilms of S. aureus isolates by ca. 1.5 log(10) to >= 2.5 log(10). Gentamicin reduced colony biofilm CFUs by >= 1.4 log(10) at these concentrations with gentamicin-susceptible isolates. Following 7 days of exposure, vancomycin and rifampicin were ineffective as single agents or in combination in the colony model, but yielded CFU decreases from 0 to 5 log(10) in the MBEC model. Treatment of biofilms with rifampicin for 7 days yielded rifampicin-resistant mutants, and the selection of rifampicin resistance was inhibited by co-treatment with ceftobiprole. Thus, ceftobiprole alone or in combination demonstrated promising activity against biofilms of meticillin-susceptible and - resistant staphylococci at clinically relevant concentrations. In contrast, vancomycin and rifampicin, two agents used clinically for the treatment of biofilm infections, tested separately or together gave inconsistent results and generally had little impact on cell viability. (C) 2013 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 31 条
[1]   Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin [J].
Anderl, JN ;
Franklin, MJ ;
Stewart, PS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1818-1824
[2]  
ANWAR H, 1992, FEMS MICROBIOL LETT, V92, P235, DOI 10.1111/j.1574-6968.1992.tb05267.x
[3]   A multiplex PCR method for the detection of all five individual genes of ica locus in Staphylococcus epidermidis.: A survey on 400 clinical isolates from prosthesis-associated infections [J].
Arciola, CR ;
Gamberini, S ;
Campoccia, D ;
Visai, L ;
Speziale, P ;
Baldassarri, L ;
Montanaro, L .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005, 75A (02) :408-413
[4]   Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus [J].
Chambers, HF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) :884-888
[5]  
Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI
[6]  
Clinical and Laboratory Standards Institute (CLSI), 2009, M07A7 CLSI
[7]  
Cunha B, 2005, ANTIBIOTIC ESSENTIAL, P365
[8]   Synergistic Activity of Ceftobiprole and Vancomycin in a Rat Model of Infective Endocarditis Caused by Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus [J].
Fernandez, Jeffrey ;
Abbanat, Darren ;
Shang, Wenchi ;
He, Wenping ;
Amsler, Karen ;
Hastings, James ;
Queenan, Anne Marie ;
Melton, John L. ;
Barron, Alfred M. ;
Flamm, Robert K. ;
Lynch, A. Simon .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (03) :1476-1484
[9]   Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? [J].
Fey, Paul D. .
CURRENT OPINION IN MICROBIOLOGY, 2010, 13 (05) :610-615
[10]   Daptomycin -: A review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia [J].
Hair, Philip I. ;
Keam, Susan J. .
DRUGS, 2007, 67 (10) :1483-1512